Form 8-K - Current report:
SEC Accession No. 0000950170-25-077880
Filing Date
2025-05-28
Accepted
2025-05-27 17:41:36
Documents
10
Period of Report
2025-05-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20250527.htm   iXBRL 8-K 74653
  Complete submission text file 0000950170-25-077880.txt   186887

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20250527.xsd EX-101.SCH 27184
12 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20250527_htm.xml XML 4940
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 25990166
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)